BioAmerica (BMRA.OB) Develops Non-Invasive Colorectal Cancer Detection Test
Colorectal cancer is the third most common form of cancer and the second-leading cause of cancer death in the United States - though if detected at an early stage, is 95 percent curable. The subject is a little touchy and invasive (no pun intended), but one company has developed a non-invasive, patented, early detection test.BioAmerica Inc. (OTCBB: BMRA) is a medical instrument supplier, developing and manufacturing medical diagnostic products designed for early detection of chronic diseases and medical conditions. The company's fecal occult blood test is the first FDA approved test with no diet restrictions or "stool handling," and is…